TAVALISSE (fostamatinib disodium hexahydrate) tablets, for oral use Initial U.S. Approval: 2018

Category: .

TAVALISSE (fostamatinib disodium hexahydrate) tablets, for oral use Initial U.S. Approval: 2018

INDICATIONS AND USAGE
TAVALISSE is a kinase inhibitor indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.
DOSAGE FORMS & STRENGTHS
Tablets: 100 mg, 150 mg
Manufactured By: Rigel Pharmaceuticals, Inc.
Prescribing Information URL: Click Here

Access to TAVALISSE ™ (fostamatinib disodium hexahydrate) tablets: Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from Medvitaz Pharma Solutions.

Fostamatinib, sold under the brand names Tavalisse and Tavlesse, is a tyrosine kinase inhibitor medication for the treatment of chronic immune thrombocytopenia (ITP).
Fostamatinib is a drug used to treat adults with low platelet count due to chronic immune thrombocytopenia (ITP) when a prior treatment for ITP has not worked well enough. Chronic immune thrombocytopenia is an autoimmune bleeding disorder where the blood doesn't clot as it should because of a low platelet count.
The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.

Reviews

There are no reviews yet.

Add a review

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.